期刊文献+

Effect of HIV-1 Tat on Secretion of TNF-α and IL-1β by U87 Cells in AIDS Patients with or without AIDS Dementia Complex 被引量:5

Effect of HIV-1 Tat on Secretion of TNF-α and IL-1β by U87 Cells in AIDS Patients with or without AIDS Dementia Complex
下载PDF
导出
摘要 Objective To explore the role of HIV-1 tat gene variations in AIDS dementia complex (ADC) pathogenesis. Methods HIV-1 tat genes derived from peripheral spleen and central basal ganglia of an AIDS patient with ADC and an AIDS patient without ADC were cloned for sequence analysis. HIV-1 tat gene sequence alignment was performed by using CLUSTAL W and the phylogentic analysis was conducted by using Neighbor-joining with MEGA4 software. All tat genes were used to construct recombinant retroviral expressing vector MSCV-IRES-GFP/tat. The MSCV-IRES-GFP/tat was cotransfected into 293T cells with pCMV-VSV-G and pUMVC vectors to assemble the recombinant retrovirus. After infection of gliomas U87 cells with equal amount of the recombinant retrovirus, TNF-α, and IL-1β concentrations in the supernatant of U87 cells were determined with ELISA. Results HIV-1 tat genes derived from peripheral spleen and central basal ganglia of the AIDS patient with ADC and the other one without ADC exhibited genetic variations. Tat variations and amino acid mutation sites existed mainly at Tat protein core functional area (38-47aa). All Tat proteins could induce ug7 cells to produce TNF-α and IL-1β, but the level of IL-1β production was different among Tat proteins derived from the ADC patient's spleen, basal ganglia, and the non-ADC patient's spleen. The level of Tat proteins derived from the ADC patient's spleen, basal ganglia, and the non-ADC patient's spleen were obviously higher than that from the non-ADC patient's basal ganglia. Conclusion Tat protein core functional area (38-47aa) may serve as the key area of enhancing the secretion of IL-1β. This may be related with the neurotoxicity of HIV-1 Tat. Objective To explore the role of HIV-1 tat gene variations in AIDS dementia complex (ADC) pathogenesis. Methods HIV-1 tat genes derived from peripheral spleen and central basal ganglia of an AIDS patient with ADC and an AIDS patient without ADC were cloned for sequence analysis. HIV-1 tat gene sequence alignment was performed by using CLUSTAL W and the phylogentic analysis was conducted by using Neighbor-joining with MEGA4 software. All tat genes were used to construct recombinant retroviral expressing vector MSCV-IRES-GFP/tat. The MSCV-IRES-GFP/tat was cotransfected into 293T cells with pCMV-VSV-G and pUMVC vectors to assemble the recombinant retrovirus. After infection of gliomas U87 cells with equal amount of the recombinant retrovirus, TNF-α, and IL-1β concentrations in the supernatant of U87 cells were determined with ELISA. Results HIV-1 tat genes derived from peripheral spleen and central basal ganglia of the AIDS patient with ADC and the other one without ADC exhibited genetic variations. Tat variations and amino acid mutation sites existed mainly at Tat protein core functional area (38-47aa). All Tat proteins could induce ug7 cells to produce TNF-α and IL-1β, but the level of IL-1β production was different among Tat proteins derived from the ADC patient's spleen, basal ganglia, and the non-ADC patient's spleen. The level of Tat proteins derived from the ADC patient's spleen, basal ganglia, and the non-ADC patient's spleen were obviously higher than that from the non-ADC patient's basal ganglia. Conclusion Tat protein core functional area (38-47aa) may serve as the key area of enhancing the secretion of IL-1β. This may be related with the neurotoxicity of HIV-1 Tat.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2014年第2期111-117,共7页 生物医学与环境科学(英文版)
基金 supported by the Science&Technology Development Program of Shandong Province(Grant No.2007GG30002003)
关键词 Key words: HIV-1 tat gene AIDS dementia complex Cytokines TNF-Α IL-1Β NEUROTOXICITY Key words: HIV-1 tat gene AIDS dementia complex Cytokines TNF-α IL-1β Neurotoxicity
  • 相关文献

参考文献27

  • 1Hogan C and Wilkins E. Neurological complications in HIV. Clin Med, 2021; 11,571-5.
  • 2Cheung R, Ravyn V, Wang LS, et al. Signaling mechanism of HIV-1 gp120 and virion-lnduced IL-II3 release in primary human macrophages. J Immunol, 2008; 180, 6675-84.
  • 3Peng H, Erdmann N, and Whitney N. HIV-l-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-113. Glia, 2006; 54, 619-29.
  • 4Dore G J, McDonald A, Li Y, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 2003; 7, 1539-45.
  • 5Tozzi V, Balestra P, Lorenzini P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from anurban observational cohort. J Neurovirol, 2005; 11, 265-73.
  • 6Mothobi NZ and Brew BJ. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis, 2012; 25, 4-9.
  • 7Spudich SS and Ances BM. Central nervous system complications of HIV infection. Top Antivir Med, 2011; 19, 48-57.
  • 8McArthur JC, Brew BJ, and Nath A. Neurological complications of HIV infection. Lancet Neurol, 2005; 4, 543-55.
  • 9Agrawal L, Louboutin JP, Reyes BA, et al. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol Dis, 2012; 45, 657-70.
  • 10Pocernich CB, Sultana HIV-dementia, Tat-induced therapeutic considerations. R, and Mohmmad-Abdul H. oxidativestress, and antioxidant Brain Research Reviews, 2005; 50, 14-26.

同被引文献22

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部